Yervoy (ipilimumab)

pCPA File Number: 20804
Negotiation Status:
Concluded with an LOI
Indication(s):
Advanced Melanoma, first-line
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
PC0042-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: